Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
VCH-222 in Chronic Hepatitis C
NCT00911963Phase 2Completed
- Sponsor
- Vertex Pharmaceuticals
- Start
- Apr 2009
- Primary completion
- Sep 2012
- Modality
- Small Molecules
- Countries
- 4
01
Overview
A Phase 2 trial of lomibuvir in hepatitis C (HCV), sponsored by Vertex Pharmaceuticals. Started Apr 2009; status: completed.
02
Drugs
lomibuvir
03
Conditions
hepatitis C (HCV)
Beyond the preview
Go deeper on NCT00911963.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00911963.